GB2318511A — Process for the preparation of a pharmaceutical composition for rapid suspension in water
Assigned to Adare Pharmaceuticals SRL · Expires 1998-04-29 · 28y expired
What this patent protects
The invention provides a process for the preparation of a pharmaceutical composition in the form of single doses adapted to be added to water to produce a suspension of a drug. The process comprises subjecting a mixture of a thickening agent and a disintegrating agent to wet gran…
USPTO Abstract
The invention provides a process for the preparation of a pharmaceutical composition in the form of single doses adapted to be added to water to produce a suspension of a drug. The process comprises subjecting a mixture of a thickening agent and a disintegrating agent to wet granulation with an aqueous medium as wetting agent or dry granulation to make a granular product and preparing the pharmaceutical composition from the granular product and the drug. A water-soluble inert excipient, which may be a sugar, may be mixed with the granular product prior to mixing with the drug.
Drugs covered by this patent
- Pulmicort Respules (BUDESONIDE) · AstraZeneca K.K.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.